MyAverix Finance
F · Healthcare
Fuji Pharma Co. Ltd (FUP)
Drug Manufacturers - Specialty & Generic
Fuji Pharma Co. Ltd (FUP) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $337.45M, P/E ratio is 20.30, net margin is 4.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for FUP
Fuji Pharma Co. Ltd (FUP) — FAQ
What is Fuji Pharma Co. Ltd's market cap?
Fuji Pharma Co. Ltd (FUP) has a reported market cap of $337.45M (data as of 2026-03-29).
What is FUP's P/E ratio?
The price-to-earnings (P/E) ratio for Fuji Pharma Co. Ltd (FUP) is 20.30 (data as of 2026-03-29).
Does Fuji Pharma Co. Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Fuji Pharma Co. Ltd (FUP). Check the MyAverix Finance app for the latest dividend data.
What sector is Fuji Pharma Co. Ltd in?
Fuji Pharma Co. Ltd (FUP) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is FUP listed on?
FUP is listed on F.
What is Fuji Pharma Co. Ltd's net margin?
Fuji Pharma Co. Ltd (FUP) reports a net margin of 4.3% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.